WO2023116788A1 - Liver organoid culture chip, liver organoid model, preparation methods therefor, and application - Google Patents

Liver organoid culture chip, liver organoid model, preparation methods therefor, and application Download PDF

Info

Publication number
WO2023116788A1
WO2023116788A1 PCT/CN2022/140800 CN2022140800W WO2023116788A1 WO 2023116788 A1 WO2023116788 A1 WO 2023116788A1 CN 2022140800 W CN2022140800 W CN 2022140800W WO 2023116788 A1 WO2023116788 A1 WO 2023116788A1
Authority
WO
WIPO (PCT)
Prior art keywords
culture
liver
liver organoid
film
cells
Prior art date
Application number
PCT/CN2022/140800
Other languages
French (fr)
Chinese (zh)
Inventor
陈璞
徐晓冬
江善青
谷龙军
Original Assignee
武汉大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 武汉大学 filed Critical 武汉大学
Publication of WO2023116788A1 publication Critical patent/WO2023116788A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • C12M1/22Petri dishes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms

Definitions

  • the outer dimension of the film matches the cell culture plate;
  • the cell culture plate includes 384-well plate, 96-well plate, 48-well plate, 24-well plate, 12-well plate, 6-well plate, 3.5cm One of Petri dish, 6cm Petri dish, 10cm Petri dish.
  • the perforated film includes a molded porous PDMS/organic silicon film or a porous PDMS/organic silicon film perforated by a puncher.
  • a culture chip of liver organoids prepared by the method is provided.
  • liver organoids include but are not limited to liver organoids derived from PSC or EB, liver organoids derived from adult stem cells, and liver-related tumor organoids.
  • the liver organoid model in pharmacology, pharmacodynamics and toxicology analysis is provided.
  • a liver organoid model provided by the present invention and its preparation method and application form a cell-specific adhesion area with a specific pattern on the bottom of the cell culture vessel through patterning technology, and perform low-adhesion or low-adhesion cell adhesion on the non-patterned area Ultra-low adhesion treatment.
  • Stem cells from different sources or different tissue sources can be inoculated on the patterned substrate. After the cells adhere to the wall, the PDMS perforated film is peeled off to obtain cell aggregates with specific edge shapes.
  • Stem cells are induced on the basal to differentiate to the liver lineage, and finally form a new type of liver organoid model with a thickness of 30-200 ⁇ m and a specific edge shape, which has high uniformity and can be imaged in situ, and is suitable for optical imaging instruments such as confocal microscopes; this liver type The organ is flattened, resembling a solid domed shape, which is different from the phenotype of previous liver organoids;
  • liver organoids in the present invention can be stained and imaged in situ in a well plate without destroying the organoid structure. ) have good compatibility.
  • a cell-specific adhesion area with a specific pattern is formed on the bottom of the cell culture vessel through patterning technology, and the non-patterned area is treated with low or ultra-low adhesion of cells, and different sources can be seeded on the patterned substrate. Or stem cells from different tissue sources. After the cells adhere to the wall, the PDMS perforated film is peeled off to obtain cell aggregates with a specific edge shape. On this patterned substrate, stem cells are induced to differentiate into the liver lineage, and finally formed with a thickness of 30- Novel liver organoid model of 200 ⁇ m and specific edge shape. High uniformity and in situ imaging, suitable for optical imaging instruments such as confocal microscopes.
  • a method for preparing a liver organoid model comprising:
  • Step S1 inoculating foregut embryonic cells in the culture chip of the liver organoid, and after the cells adhere to the wall, remove the film with multiple perforations, and aspirate the inside of the culture chip of the liver organoid After washing, add the first medium to maintain the culture for 3 to 5 days;
  • the pattern unit in the PDMS perforated film is circular, the diameter of the circular pattern is 500 ⁇ m, the pattern spacing is 1.5 mm, the cell seeding density on the patterned substrate is 9 ⁇ 10 5 cells/cm 2 , other structures and steps All with embodiment 1.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Sustainable Development (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Disclosed are a liver organoid culture chip, a liver organoid model, preparation methods therefor, and an application. The preparation method for the chip comprises: obtaining a thin film having a plurality of perforations; coating a material having low cell adhesion on the bottom of a cell culture plate, and then covering the thin film on the bottom of the cell culture plate to obtain a patterned substrate; adding a material having specific cell adhesion into the patterned substrate for coating to obtain a chip; inoculating foregut germ cells in the liver organoid culture chip, removing the thin film having the plurality of perforations after the cells adhere to the wall, suctioning a culture medium in the liver organoid culture chip, and after washing, adding a first culture medium to maintain culture for 3-5 days; and then, sequentially using a second culture medium and a third culture medium to respectively maintain culture, so as to obtain a liver organoid model. The liver organoid model is high in uniformity and can be imaged in situ, and is suitable for optical imaging instruments such as a confocal microscope.

Description

一种肝脏类器官的培养芯片、肝脏类器官模型及其制备方法与应用A culture chip of liver organoid, liver organoid model and its preparation method and application 技术领域technical field
本发明涉及组织工程和器官芯片技术领域,特别涉及一种肝脏类器官的培养芯片、肝脏类器官模型及其制备方法与应用。The invention relates to the technical fields of tissue engineering and organ chips, in particular to a culture chip of liver organoids, a model of liver organoids, a preparation method and application thereof.
背景技术Background technique
肝脏是人体重要器官,具有多种重要生理功能,包括解毒、消化和代谢等。然而,相关肝脏疾病如病毒性肝炎、非酒精性脂肪肝、肝癌等疾病造成了沉重的社会负担,严重威胁人类的生命健康。因此,为了揭示肝脏疾病发生发展的机制,开发肝脏疾病的治疗方法,建立与人体高度相关的肝脏研究模型具有重要意义。肝脏类器官是一种新兴的肝脏研究模型,具有人类肝脏的关键特征,如细胞构成和白蛋白合成、糖原合成、脂质积累等功能特征,在基础研究、药物研发等领域具有广泛的应用。与传统的动物模型相比,类器官模型不存在种属差异,具有和人体高度相关的表观代谢能力;与二维培养模型相比,具有与体内相似的细胞微环境、具有肝组织特异性细胞种群、能够模拟实质细胞和非实质细胞间的相互作用等优势。目前肝脏类器官克服了癌细胞系和PDX模型的局限性,能够培养来自同一患者的病变和健康组织,提供与患者相匹配的个性化药物测试平台,同时为疾病机制研究提供了理想模型。由此可见,体外肝脏类器官的构建为研究肝脏发病机制和治疗方法开发提供了一个有效的模型系统。The liver is an important organ of the human body and has a variety of important physiological functions, including detoxification, digestion and metabolism. However, related liver diseases such as viral hepatitis, non-alcoholic fatty liver, liver cancer and other diseases have caused a heavy social burden and seriously threatened human life and health. Therefore, in order to reveal the mechanism of the occurrence and development of liver diseases and develop therapeutic methods for liver diseases, it is of great significance to establish a liver research model that is highly relevant to the human body. Liver organoids are an emerging research model of the liver. They have key features of the human liver, such as cell structure and functional characteristics such as albumin synthesis, glycogen synthesis, and lipid accumulation. They have a wide range of applications in basic research, drug development, and other fields. . Compared with traditional animal models, the organoid model has no species difference, and has an apparent metabolic capacity that is highly related to the human body; compared with the two-dimensional culture model, it has a similar cellular microenvironment to the body and is specific for liver tissue Cell populations, the ability to simulate the interaction between parenchymal cells and non-parenchymal cells, etc. At present, liver organoids overcome the limitations of cancer cell lines and PDX models, and can cultivate diseased and healthy tissues from the same patient, providing a personalized drug testing platform that matches the patient, and providing an ideal model for the study of disease mechanisms. It can be seen that the construction of liver organoids in vitro provides an effective model system for the study of liver pathogenesis and the development of therapeutic methods.
目前,肝脏类器官的培养主要以Matrigel胶滴培养法为主。胶滴法的制作过程是将干细胞随机包裹在胶滴中,这使得胶滴内和胶滴间存在异质性,具体表现在形态、尺寸、成熟度、细胞种群,难以进行原位的光学成像,难以实现类器官生产的一致性和再现性。已有的方法虽能进行原位三维成球,但无法高通量的进行原位成像,其原因是类器官Z轴高度超过了目前光学显微镜(如共聚焦显微镜、倒置荧光显微镜)的成像极限,因此需要将类器官取出进行切片再成像,过程繁琐,无法解释三维的原位结构,而这些问题严重影响了肝脏类器官在生物医学领域的商业化应用。At present, the culture of liver organoids is mainly based on the Matrigel droplet culture method. The production process of the glue drop method is to randomly wrap the stem cells in the glue droplet, which leads to the heterogeneity in the glue droplet and between the glue droplet, which is manifested in the shape, size, maturity, and cell population, making it difficult to perform in situ optical imaging. , it is difficult to achieve consistent and reproducible organoid production. Although the existing methods can perform in situ three-dimensional sphere formation, they cannot perform high-throughput in situ imaging. The reason is that the Z-axis height of organoids exceeds the imaging limit of current optical microscopes (such as confocal microscopes and inverted fluorescence microscopes). , so the organoids need to be taken out for sectioning and re-imaging. The process is cumbersome and cannot explain the three-dimensional in situ structure. These problems have seriously affected the commercial application of liver organoids in the biomedical field.
因此,为了克服上述培养方法存在的问题,急需开发一种高均一性、可原位成像的肝脏类器官的培养芯片、新型肝脏类器官模型,适用于共聚焦显微镜等光学成像仪器,尤其是药物开发行业中的高通量筛选的金标准——高内涵荧光成像和细胞分析系统,从而为肝脏基础研究和药物研发提供一个创新性研究工具。Therefore, in order to overcome the problems of the above-mentioned culture methods, it is urgent to develop a culture chip of liver organoids with high uniformity and in situ imaging, and a new liver organoid model, which is suitable for optical imaging instruments such as confocal microscopes, especially for drugs. Develop the gold standard of high-throughput screening in the industry - high-content fluorescence imaging and cell analysis system, so as to provide an innovative research tool for liver basic research and drug development.
发明内容Contents of the invention
本发明目的是提供一种肝脏类器官的培养芯片、肝脏类器官模型及其制备方法与应用,均一性高且可原位成像,适用于共聚焦显微镜等光学成像仪器。The object of the present invention is to provide a liver organoid culture chip, a liver organoid model and its preparation method and application, which have high uniformity and can be imaged in situ, and are suitable for optical imaging instruments such as confocal microscopes.
为了实现上述目的,本发明采用如下技术方案:In order to achieve the above object, the present invention adopts the following technical solutions:
在本发明的第一方面,提供了一种肝脏类器官的培养芯片的制备方法,所述方法包括:In the first aspect of the present invention, a method for preparing a culture chip of liver organoids is provided, the method comprising:
获得具有多个穿孔的薄膜;obtaining a film with a plurality of perforations;
将细胞低黏附的材料包被在细胞培养板底部,后将所述薄膜覆盖于所述细胞培养板底部,获得图案化基底;coating the bottom of the cell culture plate with a material with low cell adhesion, and then covering the bottom of the cell culture plate with the film to obtain a patterned substrate;
向所述图案化基底中加入细胞特异性黏附的材料进行包被,获得肝脏类器官的培养芯片。A cell-specific adhesion material is added to the patterned substrate for coating to obtain a culture chip of liver organoids.
进一步地,每个所述穿孔的孔形状包括圆形、椭圆形、半圆形、扇形、三角形、四边形、五边形、六边形和任意多边形中的一种;每个所述穿孔的外接圆直径为100μm~1000μm,所述薄膜的相邻两个所述穿孔的间距为0.5mm~3mm。Further, the hole shape of each perforation includes one of circle, ellipse, semicircle, sector, triangle, quadrilateral, pentagon, hexagon and any polygon; the circumscribed shape of each perforation The diameter of the circle is 100 μm-1000 μm, and the distance between two adjacent perforations of the film is 0.5 mm-3 mm.
进一步地,所述薄膜的材料包括聚二甲基硅氧烷;所述细胞低黏附的材料包括聚乙二醇;所述细胞特异性黏附的材料包括Matrigel和Collagen中的至少一种。Further, the film material includes polydimethylsiloxane; the low cell adhesion material includes polyethylene glycol; and the cell specific adhesion material includes at least one of Matrigel and Collagen.
进一步地,所述薄膜的外形尺寸与所述细胞培养板相匹配;所述细胞培养板包括384孔板、96孔板、48孔板、24孔板、12孔板、6孔板、3.5cm培养皿、6cm培养皿、10cm培养皿中的一种。Further, the outer dimension of the film matches the cell culture plate; the cell culture plate includes 384-well plate, 96-well plate, 48-well plate, 24-well plate, 12-well plate, 6-well plate, 3.5cm One of Petri dish, 6cm Petri dish, 10cm Petri dish.
进一步地,所述获得具有多个穿孔的薄膜,包括:Further, said obtaining a film with multiple perforations includes:
获得具有多个微柱阵列的阳模;obtaining a male mold with a plurality of micropillar arrays;
将PDMS倒入所述阳模上,真空干燥并抽真空,并在所述PDMS上覆盖一层PMMA,后用两个玻璃片夹紧固定,烘干;Pour the PDMS onto the positive mold, vacuum dry and evacuate, and cover a layer of PMMA on the PDMS, then clamp and fix it with two glass sheets, and dry;
将凝固的PDMS层取出,并裁剪成适配于细胞培养板形状的PDMS膜,获得具有多个穿孔的薄膜。The solidified PDMS layer was taken out and cut into a PDMS membrane adapted to the shape of the cell culture plate to obtain a thin film with multiple perforations.
进一步地,所述阳膜的所述微柱阵列高度为30μm~100μm。Further, the height of the micropillar array of the positive membrane is 30 μm˜100 μm.
进一步地,所述穿孔的薄膜包括模型成型的多孔PDMS/有机硅薄膜或打孔器穿孔的多孔PDMS/有机硅薄膜。Further, the perforated film includes a molded porous PDMS/organic silicon film or a porous PDMS/organic silicon film perforated by a puncher.
在本发明的第二方面,提供了一种采用所述的方法制备得到的肝脏类器官的培养芯片。In the second aspect of the present invention, a culture chip of liver organoids prepared by the method is provided.
在本发明的第三方面,提供了一种肝脏类器官模型的制备方法,所述方法包括:In a third aspect of the present invention, a method for preparing a liver organoid model is provided, the method comprising:
于所述的肝脏类器官的培养芯片内接种前肠胚细胞,待细胞贴壁后,将所述具有多个穿孔的薄膜移走,吸除所述的肝脏类器官的培养芯片内的培养基,洗涤后加入第一培养基 维持培养3~5天;Inoculate the foregut embryonic cells in the culture chip of the liver organoid, and after the cells adhere to the wall, remove the film with multiple perforations, and suck off the culture medium in the culture chip of the liver organoid After washing, add the first medium to maintain the culture for 3 to 5 days;
后依次采用第二培养基维持培养3~5天和第三培养基维持培养≥10天,获得肝脏类器官模型。Afterwards, the second culture medium was used to maintain culture for 3 to 5 days and the third culture medium for ≥10 days to obtain a liver organoid model.
进一步地,所述前肠胚细胞的接种密度为1×10 5~9×10 5(个/cm 2)。 Further, the seeding density of the foregut embryo cells is 1×10 5 -9×10 5 (cells/cm 2 ).
上述技术方案中,肝脏类器官的类型包括但不限于PSC或者EB来源的肝脏类器官、成体干细胞来源的肝脏类器官、肝脏相关的肿瘤类器官。In the above technical solution, the types of liver organoids include but are not limited to liver organoids derived from PSC or EB, liver organoids derived from adult stem cells, and liver-related tumor organoids.
在本发明的第四方面,提供了一种采用所述的方法获得的肝脏类器官模型。In the fourth aspect of the present invention, a liver organoid model obtained by the method is provided.
在本发明的第五方面,提供了所述的肝脏类器官模型在药理学、药效学、毒理学分析中的应用。In the fifth aspect of the present invention, the application of the liver organoid model in pharmacology, pharmacodynamics and toxicology analysis is provided.
本发明实施例中的一个或多个技术方案,至少具有如下技术效果或优点:One or more technical solutions in the embodiments of the present invention have at least the following technical effects or advantages:
(1)本发明提供的一种肝脏类器官模型及其制备方法与应用,通过图案化技术在细胞培养器皿底部形成具有特定图案的细胞特异性黏附区域,并对非图案区域进行细胞低黏附或超低黏附处理,在此图案化基底上可以接种不同来源或不同组织来源的干细胞,待细胞贴壁后,将PDMS穿孔薄膜揭走,获得具有特定边缘形状的细胞聚集体,在所述图案化基底上诱导干细胞向肝脏谱系分化,最终形成具有厚度在30-200μm和特定边缘形状的新型肝脏类器官模型,均一性高且可原位成像,适用于共聚焦显微镜等光学成像仪器;此肝脏类器官是扁平的,类似于一个实心圆拱型,这是不同于以往肝脏类器官的表型;(1) A liver organoid model provided by the present invention and its preparation method and application, form a cell-specific adhesion area with a specific pattern on the bottom of the cell culture vessel through patterning technology, and perform low-adhesion or low-adhesion cell adhesion on the non-patterned area Ultra-low adhesion treatment. Stem cells from different sources or different tissue sources can be inoculated on the patterned substrate. After the cells adhere to the wall, the PDMS perforated film is peeled off to obtain cell aggregates with specific edge shapes. Stem cells are induced on the basal to differentiate to the liver lineage, and finally form a new type of liver organoid model with a thickness of 30-200 μm and a specific edge shape, which has high uniformity and can be imaged in situ, and is suitable for optical imaging instruments such as confocal microscopes; this liver type The organ is flattened, resembling a solid domed shape, which is different from the phenotype of previous liver organoids;
(2)本发明的图案化基底阵列可以根据具体需求进行设计和定制,适用于多种类型的类器官或细胞培养;(2) The patterned substrate array of the present invention can be designed and customized according to specific needs, and is suitable for various types of organoids or cell culture;
(3)本发明的穿孔薄膜适用于多种市售细胞培养器皿,制备过程操作简单易理解,学习成本低,对于普通实验室和批量生产均有较好的优势;(3) The perforated film of the present invention is suitable for a variety of commercially available cell culture vessels, the preparation process is simple and easy to understand, and the learning cost is low, and it has good advantages for ordinary laboratories and mass production;
(4)本发明中的肝脏类器官,可以在孔板中进行原位染色及成像,不会破坏类器官结构,对现有的用于药物开发领域的生物分析和成像仪器(如高内涵仪器)均有良好的兼容性。(4) The liver organoids in the present invention can be stained and imaged in situ in a well plate without destroying the organoid structure. ) have good compatibility.
(5)本发明的图案化基底易于大批量标准化生产,适用范围广,能够满足用于需求,非常易于实现商业化生产。(5) The patterned substrate of the present invention is easy to produce in large quantities and standardized, has a wide range of applications, can meet the needs of users, and is very easy to realize commercial production.
附图说明Description of drawings
为了更清楚地说明本发明实施例中的技术方案,下面将对实施例描述中所需要使用的附图作一简单地介绍,显而易见地,下面描述中的附图是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其它的附 图。In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the following will briefly introduce the drawings that need to be used in the description of the embodiments. Obviously, the drawings in the following description are some embodiments of the present invention. For those skilled in the art, other drawings can also be obtained based on these drawings without creative effort.
图1为本发明实施例提供的肝脏类器官的培养芯片的图案化基底制备流程图及实物图;其中图1a为图案化基底制备流程图;图1b、图1c和图1d为实物图;Fig. 1 is the flow chart and physical map of the patterned substrate preparation of the liver organoid culture chip provided by the embodiment of the present invention; wherein Fig. 1a is the patterned substrate preparation flow chart; Fig. 1b, Fig. 1c and Fig. 1d are the physical maps;
图2为本发明实施例提供的肝脏类器官的培养芯片的图案化基底上人源肝脏类器官的培养及表征;其中图2a为图案化肝脏类器官培养流程图;图2b为24孔板中肝脏类器官明场图;图2c为传统胶滴法培养的肝脏类器官明场图;图2d为图案化肝脏类器官培养到不同时间点的面积表征;图2e为图案化肝脏类器官和胶滴法肝脏类器官面积变异系数(CV值)比较;Figure 2 is the culture and characterization of human liver organoids on the patterned substrate of the culture chip of liver organoids provided by the embodiment of the present invention; Figure 2a is a flow chart of patterned liver organoid culture; Figure 2b is a 24-well plate Bright field images of liver organoids; Figure 2c is a bright field image of liver organoids cultured by the traditional glue drop method; Figure 2d is the area representation of patterned liver organoids cultured to different time points; Figure 2e is the patterned liver organoids and glue Comparison of coefficient of variation (CV value) of liver organoid area by drop method;
图3为人源肝脏类器官构建各阶段蛋白水平和转录水平鉴定;其中图3a为hiPSC阶段和前肠胚阶段标志物的表达情况;图3b为图案化肝脏类器官不同时间点相关干性标志物和双向分化潜能标志物的表达情况;图3c为图案化肝脏类器官肝脏谱系标志物的表达情况;图3d为图案化肝脏类器官相关基因表达情况;Figure 3 is the identification of protein levels and transcription levels at various stages of human liver organoid construction; Figure 3a shows the expression of markers at the hiPSC stage and foregut embryo stage; Figure 3b shows the stemness markers at different time points in patterned liver organoids and the expression of bidirectional differentiation potential markers; Figure 3c is the expression of liver lineage markers in patterned liver organoids; Figure 3d is the expression of related genes in patterned liver organoids;
图4为本发明实施例提供的肝脏类器官的培养芯片的图案化基底中药物肝毒性评价体系的构建与表征结果。Fig. 4 shows the construction and characterization results of the drug hepatotoxicity evaluation system in the patterned substrate of the liver organoid culture chip provided by the embodiment of the present invention.
具体实施方式Detailed ways
下文将结合具体实施方式和实施例,具体阐述本发明,本发明的优点和各种效果将由此更加清楚地呈现。本领域技术人员应理解,这些具体实施方式和实施例是用于说明本发明,而非限制本发明。The present invention will be described in detail below in conjunction with specific embodiments and examples, and the advantages and various effects of the present invention will be presented more clearly. Those skilled in the art should understand that these specific implementations and examples are used to illustrate the present invention, not to limit the present invention.
在整个说明书中,除非另有特别说明,本文使用的术语应理解为如本领域中通常所使用的含义。因此,除非另有定义,本文使用的所有技术和科学术语具有与本发明所属领域技术人员的一般理解相同的含义。若存在矛盾,本说明书优先。Throughout the specification, unless otherwise specified, terms used herein should be understood as commonly used in the art. Therefore, unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In case of conflict, this specification shall take precedence.
需要说明的是,当元件被称为“固定于”或“设于”另一个元件上,它可以直接在另一个元件上或者间接设在另一个元件上;当一个元件被称为是“连接于”另一个元件,它可以是直接连接到另一个元件或间接连接至另一个元件上。It should be noted that when an element is said to be "fixed" or "set on" another element, it can be directly on another element or indirectly set on another element; when an element is said to be "connected" It may be directly connected to another element or indirectly connected to another element.
需要理解的是,术语“长度”、“宽度”、“上”、下”、“前”、“后”、“第一”、“第二”、“竖直”、“水平”、“顶”、“底”、“内”、“外”等指示的方位或位置关系为基于附图所示的方位或位置关系,仅是为了便于描述本申请和简化描述,而不是指示或暗示所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本申请的限制。It is to be understood that the terms "length", "width", "upper", "lower", "front", "rear", "first", "second", "vertical", "horizontal", "top ", "bottom", "inner", "outer" and other indicated orientations or positional relationships are based on the orientations or positional relationships shown in the drawings, and are only for the convenience of describing the application and simplifying the description, rather than indicating or implying Any device or element must have a specific orientation, be constructed, and operate in a specific orientation, and therefore should not be construed as limiting the application.
此外,在本申请的描述中,“多个”、“若干个”的含义是两个或两个以上,除非另有明确具体的限定。In addition, in the description of the present application, the meanings of "plurality" and "several" are two or more, unless otherwise specifically defined.
本申请的技术方案总体思路如下:The general idea of the technical scheme of this application is as follows:
根据本发明的一种典型的实施方式,提供肝脏类器官的培养芯片的制备方法,所述方法包括:According to a typical embodiment of the present invention, a method for preparing a culture chip of liver organoids is provided, the method comprising:
获得具有多个穿孔的薄膜;obtaining a film with a plurality of perforations;
将细胞低黏附的材料包被在细胞培养板底部,后将所述薄膜覆盖于所述细胞培养板底部,获得图案化基底;coating the bottom of the cell culture plate with a material with low cell adhesion, and then covering the bottom of the cell culture plate with the film to obtain a patterned substrate;
向所述图案化基底中加入细胞特异性黏附的材料进行包被,获得肝脏类器官的培养芯片。A cell-specific adhesion material is added to the patterned substrate for coating to obtain a culture chip of liver organoids.
上述技术方案中,通过图案化技术在细胞培养器皿底部形成具有特定图案的细胞特异性黏附区域,并对非图案区域进行细胞低黏附或超低黏附处理,在此图案化基底上可以接种不同来源或不同组织来源的干细胞,待细胞贴壁后,将PDMS穿孔薄膜揭走,获得具有特定边缘形状的细胞聚集体,在此图案化基底上诱导干细胞向肝脏谱系分化,最终形成具有厚度在30-200μm和特定边缘形状的新型肝脏类器官模型。均一性高且可原位成像,适用于共聚焦显微镜等光学成像仪器。In the above technical scheme, a cell-specific adhesion area with a specific pattern is formed on the bottom of the cell culture vessel through patterning technology, and the non-patterned area is treated with low or ultra-low adhesion of cells, and different sources can be seeded on the patterned substrate. Or stem cells from different tissue sources. After the cells adhere to the wall, the PDMS perforated film is peeled off to obtain cell aggregates with a specific edge shape. On this patterned substrate, stem cells are induced to differentiate into the liver lineage, and finally formed with a thickness of 30- Novel liver organoid model of 200 μm and specific edge shape. High uniformity and in situ imaging, suitable for optical imaging instruments such as confocal microscopes.
作为一种优选的实施方式,每个所述穿孔的孔形状包括圆形、椭圆形、半圆形、扇形、三角形、四边形、五边形、六边形和任意多边形中的一种;每个所述穿孔的外接圆直径为100μm~1000μm,所述薄膜的相邻两个所述穿孔的间距为0.5mm~3mm。As a preferred embodiment, the hole shape of each perforation includes one of circle, ellipse, semicircle, sector, triangle, quadrangle, pentagon, hexagon and any polygon; The diameter of the circumscribed circle of the perforation is 100 μm to 1000 μm, and the distance between two adjacent perforations of the film is 0.5 mm to 3 mm.
若每个所述穿孔的外接圆直径小于100μm,存在类器官在换液时容易丢失的缺点,若外接圆直径过大,存在通量低缺点;If the diameter of the circumscribed circle of each perforation is less than 100 μm, there is a disadvantage that organoids are easily lost during liquid exchange, and if the diameter of the circumscribed circle is too large, there is a disadvantage of low flux;
若所述薄膜的相邻两个所述穿孔的间距小于0.5mm,存在类器官之间容易粘连,无法独立生长的缺点;若间距过大,存在通量低缺点;多个所述穿孔可以等距排布,也可以非等距排布。If the distance between two adjacent perforations of the film is less than 0.5 mm, there is a disadvantage that organoids are easy to adhere and cannot grow independently; if the distance is too large, there is a disadvantage of low flux; multiple perforations can wait It can also be arranged at a non-equidistant distance.
作为一种具体的实施方式,所述薄膜的外形尺寸与所述细胞培养板相匹配;所述细胞培养板包括384孔板、96孔板、48孔板、24孔板、12孔板、6孔板、3.5cm培养皿、6cm培养皿、10cm培养皿中的一种。本发明的肝脏类器官模型基于现有的细胞培养孔板进行改造,与现有的细胞培养孔板高度结合,对现有的生物相关光学仪器均有良好的兼容性。As a specific embodiment, the outer dimension of the film matches the cell culture plate; the cell culture plate includes 384-well plate, 96-well plate, 48-well plate, 24-well plate, 12-well plate, 6 One of orifice plate, 3.5cm Petri dish, 6cm Petri dish, 10cm Petri dish. The liver organoid model of the present invention is modified based on the existing cell culture well plate, highly combined with the existing cell culture well plate, and has good compatibility with the existing biological related optical instruments.
作为一种具体的实施方式,As a specific implementation,
所述薄膜的材料包括聚二甲基硅氧烷;The material of the film comprises polydimethylsiloxane;
所述细胞低黏附的材料包括聚乙二醇;在其他实施方式中也可采用其他细胞低黏附的材料;The low cell adhesion material includes polyethylene glycol; in other embodiments, other low cell adhesion materials can also be used;
所述细胞特异性黏附的材料包括Matrigel和Collagen中的至少一种。The material for cell-specific adhesion includes at least one of Matrigel and Collagen.
作为一种具体的实施方式,所述获得具有多个穿孔的薄膜,包括:As a specific implementation, the obtaining a film with multiple perforations includes:
获得具有多个微柱阵列的阳模;obtaining a male mold with a plurality of micropillar arrays;
将PDMS倒入所述阳模上,真空干燥并抽真空,并在所述PDMS上覆盖一层PMMA,后用两个玻璃片夹紧固定,烘干;Pour the PDMS onto the positive mold, vacuum dry and evacuate, and cover a layer of PMMA on the PDMS, then clamp and fix it with two glass sheets, and dry;
将凝固的PDMS层取出,并裁剪成适配于细胞培养板形状的PDMS膜,获得具有多个穿孔的薄膜。The solidified PDMS layer was taken out and cut into a PDMS membrane adapted to the shape of the cell culture plate to obtain a thin film with multiple perforations.
其中,所述阳膜的所述微柱阵列高度为30μm~100μm。若高度过低有压出来的PDMS薄膜过薄,不容易展开;高度过高有不容易穿孔;Wherein, the height of the micropillar array of the positive membrane is 30 μm˜100 μm. If the height is too low, the extruded PDMS film is too thin, and it is not easy to unfold; if the height is too high, it is not easy to perforate;
根据本发明实施例另一种典型的实施方式,提供了采用所述的方法制备得到的肝脏类器官的培养芯片。According to another typical implementation of the embodiments of the present invention, a culture chip of liver organoids prepared by the method is provided.
根据本发明实施例另一种典型的实施方式,提供肝脏类器官模型的制备方法,所述方法包括:According to another typical implementation of the embodiments of the present invention, a method for preparing a liver organoid model is provided, the method comprising:
步骤S1、于所述的肝脏类器官的培养芯片内接种前肠胚细胞,待细胞贴壁后,将所述具有多个穿孔的薄膜移走,吸除所述的肝脏类器官的培养芯片内的培养基,洗涤后加入第一培养基维持培养3~5天;Step S1, inoculating foregut embryonic cells in the culture chip of the liver organoid, and after the cells adhere to the wall, remove the film with multiple perforations, and aspirate the inside of the culture chip of the liver organoid After washing, add the first medium to maintain the culture for 3 to 5 days;
所述步骤S1,具体包括:The step S1 specifically includes:
S101、诱导干细胞(hESCs或hiPSCs)向内胚层分化:常规培养的hESCs或hiPSCs用Accutase消化成单个细胞,按1×10 5个/cm 2的密度铺种的六孔板中,待细胞融合度达到85%-90%时开始分化。培养时间为1~3天,采用D1-D3培养基培养: S101. Differentiation of stem cells (hESCs or hiPSCs) to endoderm: conventionally cultured hESCs or hiPSCs were digested with Accutase into single cells, and planted in a six-well plate at a density of 1×10 5 cells/cm 2 until the cells were confluent. Differentiation begins when it reaches 85%-90%. The culture time is 1 to 3 days, and cultured in D1-D3 medium:
D1 Medium:含有100ng/mL ActivinA和50ng/mL BMP4的RPMI培养基;D2 Medium:含有100ng/mL ActivinA和0.2%Knockout serum replacement的RPMI培养基;D3 Medium:含有100ng/mL ActivinA和2%Knockout serum replacement的RPMI培养基。D1 Medium: RPMI medium containing 100ng/mL ActivinA and 50ng/mL BMP4; D2 Medium: RPMI medium containing 100ng/mL ActivinA and 0.2% Knockout serum replacement; D3 Medium: containing 100ng/mL ActivinA and 2% Knockout serum Replacement with RPMI medium.
S102、内胚层细胞向前肠胚细胞分化:用分化培养基进行培养;每天更换培养基,细胞在培养箱中常规二维培养。分化的第6天可见明显三维结构。S102. Differentiation of endoderm cells into foregut embryo cells: culturing with differentiation medium; replacing the medium every day, and routinely culturing the cells in a two-dimensional incubator. On the 6th day of differentiation, obvious three-dimensional structure can be seen.
所述分化培养基为本发明实施例的D4-6Medium;所述分化培养基的配方为终浓度为450~550ng/mL FGF2、2~4μM CHIR99021、1%B27和1%N2的Advanced DMEM/F12培养基,优选为500ng/mL FGF2和3μM CHIR99021;The differentiation medium is D4-6Medium according to the embodiment of the present invention; the formulation of the differentiation medium is Advanced DMEM/F12 with a final concentration of 450-550ng/mL FGF2, 2-4μM CHIR99021, 1% B27 and 1% N2 Medium, preferably 500ng/mL FGF2 and 3μM CHIR99021;
本发明的B27和N2为无血清培养添加剂。1%B27和1%N2中的“%”为质量分数。B27 and N2 of the present invention are serum-free culture additives. "%" in 1%B27 and 1%N2 is the mass fraction.
S103、将所述前肠胚细胞消化下来后接种到所述的肝脏类器官的培养芯片的图案化基底上,加入第一培养基维持培养3~5天。S103. Digest the foregut embryo cells and inoculate them on the patterned substrate of the liver organoid culture chip, and add the first culture medium to maintain the culture for 3-5 days.
所述前肠胚细胞的接种密度为1×10 5~9×10 5(个/cm 2)。若细胞接种密度过小,存在难 以生长成具有一定厚度的类器官的缺点;若细胞接种密度过大,存在细胞过多,难以与PDMS穿孔薄膜分离,不能形成图案化分布的类器官的缺点。 The inoculation density of the foregut germ cells is 1×10 5 -9×10 5 (unit/cm 2 ). If the cell seeding density is too low, it is difficult to grow into organoids with a certain thickness; if the cell seeding density is too high, there are too many cells, it is difficult to separate from the PDMS perforated film, and it is impossible to form patterned organoids.
所述第一培养基的配方为终浓度为75~85ng/mL FGF2、2~4μM CHIR99021、1%B27和1%N2的Advanced DMEM/F12培养基,优选为80ng/mL FGF2和3μM CHIR99021;The formulation of the first medium is Advanced DMEM/F12 medium with a final concentration of 75-85ng/mL FGF2, 2-4μM CHIR99021, 1% B27 and 1%N2, preferably 80ng/mL FGF2 and 3μM CHIR99021;
步骤S2、后依次采用第二培养基维持培养3~5天和第三培养基维持培养≥10天,获得肝脏类器官模型。In step S2, the liver organoid model is obtained by sequentially adopting the second medium for maintaining culture for 3-5 days and the third medium for maintaining culture for ≥10 days.
所述步骤S2中,In the step S2,
第二培养基的配方为终浓度为1~3mM RA、1%B27和1%N2的Advanced DMEM/F12,优选为含有2mM RA;The formula of the second culture medium is the Advanced DMEM/F12 that final concentration is 1~3mM RA, 1%B27 and 1%N2, preferably contains 2mM RA;
第三培养基的配方为终浓度为8~12ng/mL HGF、0.05~0.2mM Dexamethasone、18~22ng/mL OSM的Hepatocyte Culture Medium培养基,优选为10ng/mL HGF、0.1mM Dexamethasone、20ng/mL OSM的Hepatocyte Culture Medium培养基;The formula of the third culture medium is the Hepatocyte Culture Medium medium that final concentration is 8~12ng/mL HGF, 0.05~0.2mM Dexamethasone, 18~22ng/mL OSM, preferably 10ng/mL HGF, 0.1mM Dexamethasone, 20ng/mL OSM's Hepatocyte Culture Medium;
根据本发明另一种典型实施方式,提供了采用所述的方法获得的肝脏类器官模型。作为本发明实施例一种具体的实施方式,获得的肝脏类器官是扁平的,类似于一个实心圆拱形(或者类似表述),这是不同于以往肝脏类器官的表型;由于类器官的一面是黏附在板底的,且类器官也是具有一定厚度的;通过荧光图的结果来看,类器官的四周清楚可见而中间部分透光性较差,所以中间的厚度应是比周边厚的,说明是实心圆拱形。According to another typical embodiment of the present invention, a liver organoid model obtained by the method is provided. As a specific implementation of the embodiment of the present invention, the obtained liver organoid is flat, similar to a solid round arch (or similar expression), which is different from the previous liver organoid phenotype; due to the organoid One side is adhered to the bottom of the plate, and the organoid also has a certain thickness; according to the results of the fluorescence image, the surrounding of the organoid is clearly visible and the middle part has poor light transmission, so the thickness in the middle should be thicker than the surrounding , indicating that it is a solid circular arch.
所述“实心圆拱形”具体结构为:肝脏类器官的中间部分拱起,中间部分与肝脏类器官的周边成圆弧形;而拱形为立体概念,半圆形为平面概念。所述“实心圆拱形”所描述的形状也可用其他表述,只要能够表征本发明所得的所述肝脏类器官。The specific structure of the "solid circular arch" is: the middle part of the liver organoid is arched, and the middle part forms a circular arc with the periphery of the liver organoid; the arch is a three-dimensional concept, and the semicircle is a planar concept. The shape described by the "solid circular arch" can also be expressed in other ways, as long as it can characterize the liver organoid obtained in the present invention.
根据本发明另一种典型实施方式,提供了所述的肝脏类器官模型在药理学、药效学、毒理学分析中的应用。According to another typical embodiment of the present invention, applications of the liver organoid model in pharmacology, pharmacodynamics, and toxicology analysis are provided.
所述新型肝脏类器官模型制备方法包括将干细胞诱导成前肠胚细胞,将前肠胚细胞以一定密度种植在图案化基底上,由前肠胚细胞向肝脏谱系分化,最终形成黏附于培养器皿底部同时具有一定厚度和特定边缘形状的类似于拱形的肝脏类器官,其包含的细胞类型包括由干细胞分化的肝样细胞、胆管样细胞、祖细胞和间质细胞;所述新型肝脏类器官模型可以应用于研究肝脏发育与疾病机制、药物筛选、药物肝毒性评价等。与传统的胶滴法和原位成球法相比,本发明提供了一种高通量、高均一性、能够原位成像的新型肝脏类器官模型,为相关肝脏研究提供了一个创新研究工具。The preparation method of the novel liver organoid model includes inducing stem cells into foregut embryo cells, planting the foregut embryo cells on a patterned substrate at a certain density, differentiating from the foregut embryo cells to the liver lineage, and finally forming an adhering culture vessel. Arch-like liver organoids with both a certain thickness at the bottom and a specific edge shape, containing cell types including hepatoid cells differentiated from stem cells, cholangioid cells, progenitor cells, and mesenchymal cells; the novel liver organoids The model can be applied to the study of liver development and disease mechanism, drug screening, drug hepatotoxicity evaluation, etc. Compared with the traditional glue drop method and in situ sphere forming method, the present invention provides a new liver organoid model with high throughput, high uniformity and in situ imaging, and provides an innovative research tool for related liver research.
下面将结合附图对本申请的一种肝脏类器官模型和培养方法进行详细说明。A liver organoid model and culture method of the present application will be described in detail below with reference to the accompanying drawings.
实施例1、一种肝脏类器官的培养芯片及其制备方法 Embodiment 1, a culture chip of liver organoid and its preparation method
一、图案化基底阵列掩膜的设计1. Design of patterned substrate array mask
使用AutoCAD 2018软件设计图案化阵列掩膜,阵列单元为0.5mm直径圆形,间距为1.5mm,阵列单元等距均匀排布。图案化阵列掩膜设计图如图1所示。Use AutoCAD 2018 software to design a patterned array mask. The array units are circular with a diameter of 0.5 mm and the pitch is 1.5 mm. The array units are evenly spaced. The patterned array mask design is shown in Figure 1.
二、图案化基底的制作Second, the production of patterned substrate
1、使用软光刻技术制备SU-8阳膜,SU-8阳膜为间距1.5mm的微柱阵列,微柱高度80μm,底面积直径为500μm。1. Prepare the SU-8 anode film by using soft lithography technology. The SU-8 anode film is a micro-column array with a pitch of 1.5 mm, the height of the micro-column is 80 μm, and the diameter of the bottom area is 500 μm.
2、将PDMS预聚物(A胶)和交联剂(B胶)按10:1的质量比混合,搅拌均匀后用真空干燥器抽除气泡。将PDMS倾倒在SU-8阳膜上,用干净的枪头将其抹平,使其均匀的覆盖在微柱阵列区域,用真空干燥器进行抽真空,直至表面没有气泡。在其表面覆盖1层0.2mm厚度的聚甲基丙烯酸甲酯(PMMA),用两个玻璃片固定后放于台钳中夹紧固定,放于80℃烘箱中烘干至少120min。2. Mix PDMS prepolymer (A glue) and crosslinking agent (B glue) at a mass ratio of 10:1, stir evenly, and use a vacuum dryer to remove air bubbles. Pour the PDMS onto the SU-8 positive film, smooth it with a clean pipette tip, make it evenly cover the area of the microcolumn array, and vacuum it with a vacuum desiccator until there are no bubbles on the surface. Cover the surface with a layer of polymethyl methacrylate (PMMA) with a thickness of 0.2mm, fix it with two glass sheets, clamp it in a vise, and dry it in an oven at 80°C for at least 120min.
3、将凝固的PDMS穿孔薄膜从台钳中取出,用15mm直径的圆冲打孔器打下圆形穿孔薄膜。3. Take out the solidified PDMS perforated film from the vise, and use a 15mm diameter circular punch to punch out a circular perforated film.
4、配置PEG mixture(PEG1000:37.5mg,PEG400:450μL,异丙醇3637.5μL,纯水112.5μL),振荡混匀3min后加入光引发剂10mg,再次振荡混匀3min,避光保存。将孔板开盖Plasma(工作电压550V)处理1min后,每孔加入150μL PEG mixture,静置5min。将孔中加有PEG mixture的孔板紫外曝光1min。曝光后的孔板用70%酒精清洗三次后,每孔加入1mL70%酒精,将圆形PDMS穿孔薄膜平整铺在液体表面,用镊子将其按压到孔板底,吸出多余液体,将孔板置于80℃烘箱烘干约20min。4. Configure PEG mixture (PEG1000: 37.5 mg, PEG400: 450 μL, isopropanol 3637.5 μL, pure water 112.5 μL), shake and mix for 3 minutes, add photoinitiator 10 mg, shake and mix again for 3 minutes, and store in the dark. After the orifice plate was treated with Plasma (operating voltage 550V) for 1 min, 150 μL PEG mixture was added to each well and allowed to stand for 5 min. Expose the well plate with PEG mixture in the well to ultraviolet exposure for 1 min. After the exposed orifice plate was washed three times with 70% alcohol, add 1mL of 70% alcohol to each well, spread the circular PDMS perforated film on the surface of the liquid, press it to the bottom of the orifice plate with tweezers, suck out the excess liquid, and place the orifice plate on the surface of the liquid. Dry in an oven at 80°C for about 20 minutes.
5、将烘干后的孔板放入等离子清洗机进行Plasma(工作电压700V),共清洗三次,每次4min,每次清洗间隔3min,间隔时间内勿取出孔板。5. Put the dried orifice plate into the plasma cleaning machine for Plasma (working voltage 700V), wash three times in total, 4 minutes each time, 3 minutes between each cleaning, and do not take out the orifice plate during the interval.
6、将制备好的孔板进行紫外灭菌60min,每孔加入1mL 1×DPBS,用移液枪反复吹打,直至孔板中没有气泡。将1×DPBS吸走,每孔加入200μL加入1%Matrigel:Advanced DMEM/F12,37℃孵育1h备用,即获得肝脏类器官的培养芯片。6. Sterilize the prepared orifice plate by ultraviolet light for 60 minutes, add 1mL 1×DPBS to each well, and pipette repeatedly until there are no air bubbles in the orifice plate. Aspirate 1×DPBS, add 200 μL to each well and add 1% Matrigel:Advanced DMEM/F12, incubate at 37°C for 1 hour for later use, and obtain the culture chip of liver organoids.
三、人源肝脏类器官的培养3. Culture of human liver organoids
1、将各实施例和对比例的图案化基底进行肝脏类器官的培养,方法如下:1. The patterned substrates of the various examples and comparative examples were cultured as liver organoids, the method is as follows:
(1)hESCs或hiPSCs向内胚层分化:常规培养的hESCs或hiPSCs用Accutase消化成单个细胞,按1×10 5个/cm 2的密度铺种的六孔板中,待细胞融合度达到85%-90%时开始分化。 (1) Differentiation of hESCs or hiPSCs to endoderm: conventionally cultured hESCs or hiPSCs were digested into single cells with Accutase, and planted in a six-well plate at a density of 1×10 5 cells/cm 2 until the cell confluence reached 85%. Differentiation begins at -90%.
(2)D1 Medium:含有100ng/mL ActivinA和50ng/mL BMP4的RPMI培养基;D2 Medium:含有100ng/mL ActivinA和0.2%Knockout serum replacement的RPMI培养基;D3 Medium: 含有100ng/mL ActivinA和2%Knockout serum replacement的RPMI培养基。(2) D1 Medium: RPMI medium containing 100ng/mL ActivinA and 50ng/mL BMP4; D2 Medium: RPMI medium containing 100ng/mL ActivinA and 0.2% Knockout serum replacement; D3 Medium: containing 100ng/mL ActivinA and 2 % RPMI medium for Knockout serum replacement.
以上D1-D3培养基用于分化的前三天,诱导干细胞向内胚层的分化;The above D1-D3 medium is used for the first three days of differentiation to induce the differentiation of stem cells into endoderm;
(3)内胚层细胞向前肠胚细胞分化:D4-6Medium:含有500ng/mL的FGF2、3μM CHIR99021、1%B27和1%N2的Advanced DMEM/F12培养基,每天更换培养基,细胞在培养箱中常规二维培养。分化的第6天可见明显三维结构。(3) Differentiation of endoderm cells into foregut germ cells: D4-6 Medium: Advanced DMEM/F12 medium containing 500ng/mL of FGF2, 3μM CHIR99021, 1% B27 and 1% N2, the medium was changed every day, and the cells were cultured Conventional two-dimensional culture in the box. On the 6th day of differentiation, obvious three-dimensional structure can be seen.
(4)图案化基底中接种前肠胚细胞:分化至第6天,用Accutase将前肠胚细胞消化成单个细胞,按3×10 5个/cm 2的密度接种到孔板中,每孔500μL含有80ng/mL FGF2、3μM CHIR99021、1%B27和1%N2的Advanced DMEM/F12培养基。 (4) Inoculation of foregut germ cells in the patterned substrate: differentiated to day 6, digested the foregut germ cells into single cells with Accutase, and inoculated them into well plates at a density of 3×10 5 cells/cm 2 , each well 500 μL of Advanced DMEM/F12 medium containing 80 ng/mL FGF2, 3 μM CHIR99021, 1% B27 and 1% N2.
(5)接种细胞至少4小时后,待细胞贴壁,用镊子将PDMS薄膜从孔板底边缘轻轻揭走。吸除孔板中的培养基,用1×DPBS轻轻洗涤细胞后,重新加入每孔500μL含有80ng/mL FGF2、3μM CHIR99021、1%B27和1%N2的Advanced DMEM/F12培养基维持培养4天,隔天换液。(5) At least 4 hours after inoculating the cells, when the cells are attached to the wall, use tweezers to gently peel off the PDMS film from the bottom edge of the well plate. Aspirate the medium in the well plate, wash the cells gently with 1×DPBS, add 500 μL per well of Advanced DMEM/F12 medium containing 80ng/mL FGF2, 3μM CHIR99021, 1% B27 and 1% N2 to maintain the culture 4 day, and change the solution every other day.
(6)图案化基底中肝脏类器官的培养:第10-14天用含有2mM RA、1%B27和1%N2的Advanced DMEM/F12维持培养4天,隔天换液;第14~24天用含有10ng/mL HGF、0.1mM Dexamethasone、20ng/mL OSM的Hepatocyte Culture Medium培养基维持培养十天,隔天换液。(6) Culture of liver organoids in the patterned substrate: on the 10th to 14th day, maintain the culture with Advanced DMEM/F12 containing 2mM RA, 1% B27 and 1% N2 for 4 days, and change the medium every other day; on the 14th to 24th day The Hepatocyte Culture Medium medium containing 10ng/mL HGF, 0.1mM Dexamethasone, and 20ng/mL OSM was used to maintain the culture for ten days, and the medium was changed every other day.
实施例2Example 2
本发明实施例中,用圆冲打孔器将PDMS穿孔薄膜打成10mm直径的圆形,铺于48孔板中,其他结构和步骤均同实施例1。In the embodiment of the present invention, the PDMS perforated film was punched into a circle with a diameter of 10 mm by a circular punch, and spread in a 48-well plate. Other structures and steps were the same as in Embodiment 1.
实施例3Example 3
本发明实施例中,PDMS穿孔薄膜中图案单元为圆形,圆形图案直径为500μm,图案间距1.5mm,图案化基底上的细胞接种密度为1×10 5个/cm 2,其他结构和步骤均同实施例1。 In the embodiment of the present invention, the pattern unit in the PDMS perforated film is circular, the diameter of the circular pattern is 500 μm, the pattern spacing is 1.5 mm, the cell seeding density on the patterned substrate is 1×10 5 cells/cm 2 , other structures and steps All with embodiment 1.
实施例4Example 4
本发明实施例中,PDMS穿孔薄膜中图案单元为圆形,圆形图案直径为500μm,图案间距1.5mm,图案化基底上的细胞接种密度为9×10 5个/cm 2,其他结构和步骤均同实施例1。 In the embodiment of the present invention, the pattern unit in the PDMS perforated film is circular, the diameter of the circular pattern is 500 μm, the pattern spacing is 1.5 mm, the cell seeding density on the patterned substrate is 9×10 5 cells/cm 2 , other structures and steps All with embodiment 1.
实施例5Example 5
本发明实施例中,PDMS穿孔薄膜中图案单元为圆形,圆形图案直径为100μm,图案间 距1mm,其他结构和步骤均同实施例1。In the embodiment of the present invention, the pattern unit in the PDMS perforated film is circular, the diameter of the circular pattern is 100 μm, and the pattern spacing is 1 mm. Other structures and steps are the same as in Example 1.
实施例6Example 6
本发明实施例中,PDMS穿孔薄膜中图案单元为圆形,圆形图案直径为200μm,图案间距1.2mm,其他结构和步骤均同实施例1。In the embodiment of the present invention, the pattern unit in the PDMS perforated film is circular, the diameter of the circular pattern is 200 μm, and the pattern pitch is 1.2 mm. Other structures and steps are the same as in Embodiment 1.
实施例7Example 7
本发明实施例中,PDMS穿孔薄膜中图案单元为圆形,圆形图案直径为1000μm,图案间距2mm,其他结构和步骤均同实施例1。In the embodiment of the present invention, the pattern unit in the PDMS perforated film is circular, the diameter of the circular pattern is 1000 μm, and the pattern pitch is 2 mm. Other structures and steps are the same as in Embodiment 1.
实施例8Example 8
本发明实施例中,PDMS穿孔薄膜中图案单元为圆形,圆形图案按正六边形排布(包括中心点),图案间距1mm,其他结构和步骤均同实施例1。In the embodiment of the present invention, the pattern units in the PDMS perforated film are circular, and the circular patterns are arranged in a regular hexagon (including the center point), and the pattern spacing is 1mm. Other structures and steps are the same as in the first embodiment.
实施例9Example 9
本发明实施例中,PDMS穿孔薄膜中图案单元为圆形,圆形图案按正六边形排布(包括中心点),图案间距为1.5mm,其他结构和步骤均同实施例1。In the embodiment of the present invention, the pattern units in the PDMS perforated film are circular, and the circular patterns are arranged in a regular hexagon (including the central point), and the pattern spacing is 1.5 mm. Other structures and steps are the same as in the first embodiment.
实施例10Example 10
本发明实施例中,PDMS穿孔薄膜中图案单元为圆形,圆形图案按正六边形排布(包括中心点),图案间距为2mm,其他结构和步骤均同实施例1。In the embodiment of the present invention, the pattern units in the PDMS perforated film are circular, and the circular patterns are arranged in a regular hexagon (including the central point), and the pattern spacing is 2mm. Other structures and steps are the same as in the first embodiment.
实施例11Example 11
本发明实施例中,PDMS穿孔薄膜中图案单元形状为等边三角形,边长为1mm,图案间距为2mm,其他结构和步骤均同实施例1。In the embodiment of the present invention, the shape of the pattern unit in the PDMS perforated film is an equilateral triangle, the side length is 1 mm, and the pattern spacing is 2 mm. Other structures and steps are the same as in the embodiment 1.
实施例12Example 12
本发明实施例中,PDMS穿孔薄膜中图案单元形状为等边三角形,边长为0.5mm,图案间距为1.5mm,其他结构和步骤均同实施例1。In the embodiment of the present invention, the shape of the pattern unit in the PDMS perforated film is an equilateral triangle, the side length is 0.5 mm, and the pattern spacing is 1.5 mm. Other structures and steps are the same as in embodiment 1.
实施例13Example 13
本发明实施例中,PDMS穿孔薄膜中图案单元形状为矩形,长边长度为0.5mm,短边长度为0.15mm,图案间距为1.5mm,其他结构和步骤均同实施例1。In the embodiment of the present invention, the shape of the pattern unit in the PDMS perforated film is rectangular, the length of the long side is 0.5 mm, the length of the short side is 0.15 mm, and the pattern spacing is 1.5 mm. Other structures and steps are the same as in embodiment 1.
实施例14Example 14
本发明实施例中,PDMS穿孔薄膜中图案单元形状为矩形,长边长度为1mm,短边长度为0.3mm,图案间距为2mm,其他结构和步骤均同实施例1。In the embodiment of the present invention, the shape of the pattern unit in the PDMS perforated film is rectangular, the length of the long side is 1 mm, the length of the short side is 0.3 mm, and the pattern spacing is 2 mm. Other structures and steps are the same as in embodiment 1.
对比例1Comparative example 1
该对比例为传统的Matrigel。The comparative example is conventional Matrigel.
对比例2Comparative example 2
该对比例中,PDMS穿孔薄膜中圆形图案直径为95μm,图案间距为1mm,其他结构和步骤均同实施例1。In this comparative example, the diameter of the circular pattern in the PDMS perforated film is 95 μm, the pattern pitch is 1 mm, and other structures and steps are the same as in Example 1.
对比例3Comparative example 3
该对比例中,图案化基底上的细胞接种密度为0.9×10 5(个/cm 2),小于本发明实施例1×10 5~9×10 5(个/cm 2),其他结构和步骤均同实施例1。 In this comparative example, the seeding density of cells on the patterned substrate is 0.9×10 5 (unit/cm 2 ), which is less than 1×10 5 to 9×10 5 (unit/cm 2 ) in the embodiment of the present invention. Other structures and steps All with embodiment 1.
对比例4Comparative example 4
该对比例中,图案化基底上的细胞接种密度为9.1×10 5(个/cm 2),大于本发明实施例1×10 5~9×10 5(个/cm 2)其他结构和步骤均同实施例1。 In this comparative example, the seeding density of cells on the patterned substrate is 9.1×10 5 (cells/cm 2 ), which is higher than that of the embodiment of the present invention (1×10 5 -9×10 5 (cells/cm 2 ) in other structures and steps. With embodiment 1.
对比例5Comparative example 5
该对比例中,图案间距为0.4mm,其他结构和步骤均同实施例1。In this comparative example, the pattern pitch is 0.4 mm, and other structures and steps are the same as those in Example 1.
对比例6Comparative example 6
该对比例中,图案化间距为3.2mm,其他结构和步骤均同实施例1。In this comparative example, the patterning pitch is 3.2 mm, and other structures and steps are the same as those in Embodiment 1.
实验例1Experimental example 1
对上述实施例1-14和对比例1-6的基底进行肝脏类器官培养效果统计,如表1所示,其中面积的标准差变异系数的计算方法为:变异系数C·V=(标准差SD/平均值Mean)×100%;The bases of the above-mentioned Examples 1-14 and Comparative Examples 1-6 were used to carry out statistics on the culture effect of liver organoids, as shown in Table 1, wherein the calculation method of the coefficient of variation of the standard deviation of the area is: coefficient of variation C·V=(standard deviation SD/average Mean)×100%;
表1Table 1
Figure PCTCN2022140800-appb-000001
Figure PCTCN2022140800-appb-000001
Figure PCTCN2022140800-appb-000002
Figure PCTCN2022140800-appb-000002
由表1的数据可知:It can be seen from the data in Table 1 that:
对比例1中,为传统的Matrigel培养方法,存在类器官均一性差、难以成像的缺点;In Comparative Example 1, the traditional Matrigel culture method has the disadvantages of poor organoid uniformity and difficulty in imaging;
对比例2中,图案化基底的图案单元为直径95μm的圆形,小于本发明实施例100~1000μm的范围,存在类器官在换液时容易丢失的缺点。In Comparative Example 2, the pattern unit of the patterned substrate is a circle with a diameter of 95 μm, which is smaller than the range of 100-1000 μm in the embodiment of the present invention, and there is a disadvantage that organoids are easily lost during liquid replacement.
对比例3中,细胞接种密度为0.9×10 5个/cm 2,小于本实施例1×10 5~9×10 5(个/cm 2)的范围,存在难以生长成具有一定厚度的类器官的缺点。 In Comparative Example 3, the cell seeding density was 0.9×10 5 cells/cm 2 , which was lower than the range of 1×10 5 to 9×10 5 (cells/cm 2 ) in this example, and it was difficult to grow into organoids with a certain thickness. Shortcomings.
对比例4中,细胞接种密度为9.1×10 5个/cm 2,大于本实施例1×10 5~9×10 5(个/cm 2)的范围,存在细胞过多,难以与PDMS穿孔薄膜分离,不能形成图案化分布的类器官的缺点。 In Comparative Example 4, the cell seeding density was 9.1×10 5 cells/cm 2 , which was greater than the range of 1×10 5 to 9×10 5 (cells/cm 2 ) in this example, and there were too many cells, which made it difficult to combine with the PDMS perforated film. Disadvantages of isolation and inability to form patterned distributions of organoids.
对比例5中,图案化基底的图案单元间距为0.4mm,小于本实施例0.5~3mm的范围,存在类器官之间容易粘连,无法独立生长的缺点。In Comparative Example 5, the pattern unit spacing of the patterned substrate is 0.4 mm, which is smaller than the range of 0.5-3 mm in this embodiment, and there is a disadvantage that organoids are easy to adhere and cannot grow independently.
对比例6中,图案化基底的图案单元间距为3.2mm,大于本实施例0.5~3mm的范围,存在无法实现高通量的缺点。In Comparative Example 6, the pattern unit pitch of the patterned substrate is 3.2 mm, which is greater than the range of 0.5-3 mm in this embodiment, and there is a disadvantage that high throughput cannot be achieved.
而本发明实施例1-实施例11中,正常生长,变异系数≤40%。与传统的胶滴法和原位成球法相比,本发明提供了一种高通量、高均一性、能够原位成像的新型肝脏类器官模型, 为相关肝脏研究提供了一个创新研究工具。However, in Example 1-Example 11 of the present invention, the growth is normal, and the coefficient of variation is ≤40%. Compared with the traditional glue drop method and in situ sphere forming method, the present invention provides a new liver organoid model with high throughput, high uniformity and in situ imaging, and provides an innovative research tool for related liver research.
实验例2、人源肝脏类器官特征标志物检测Experimental example 2. Detection of characteristic markers of human liver organoids
1、使用免疫荧光检测分化至各阶段特征标志物:在hESCs或hiPSCs阶段检测标志物OCT3/4、Nanog表达情况;前肠阶段检测标志物CDX2、EpCAM表达情况;肝脏类器官阶段检测标志物ALB、HNF4-α、AFP、EpCAM表达情况。1. Use immunofluorescence to detect the characteristic markers of differentiation to each stage: detect the expression of markers OCT3/4 and Nanog at the stage of hESCs or hiPSCs; detect the expression of markers CDX2 and EpCAM at the foregut stage; detect the expression of markers ALB at the stage of liver organoids , HNF4-α, AFP, EpCAM expression.
2、实施例1图案化基底上的药物肝毒性评价体系的构建与表征:在第24天时,分别使用0mM、10mM、20mM、40mM的对乙酰氨基酚(APAP)对肝脏类器官处理48小时后进行细胞死活鉴定。2. Construction and characterization of the drug hepatotoxicity evaluation system on the patterned substrate of Example 1: On the 24th day, the liver organoids were treated with 0mM, 10mM, 20mM, and 40mM acetaminophen (APAP) for 48 hours. Perform cell death assays.
结果如图3-图4,表明本发明实施例成功获得人源肝脏类器官并构建了药物肝毒性评价体系。The results are shown in Fig. 3-Fig. 4, indicating that the embodiment of the present invention successfully obtained human-derived liver organoids and established a drug hepatotoxicity evaluation system.
3、将实施例1图案化基底上进行人源类器官的培养,并采用传统胶滴法培养肝脏类器官作为对照;其中图2a为图案化肝脏类器官培养流程图;图2b为24孔板中肝脏类器官明场图;图2c为传统胶滴法培养的肝脏类器官明场图;图2d为图案化肝脏类器官培养到不同时间点的面积表征;图2e为图案化肝脏类器官和胶滴法肝脏类器官面积变异系数(CV值)比较;3. Carry out the culture of human-derived organoids on the patterned substrate of Example 1, and use the traditional glue drop method to culture liver organoids as a control; where Figure 2a is a flow chart of patterned liver organoid culture; Figure 2b is a 24-well plate Bright field image of liver organoids in the middle; Figure 2c is a bright field image of liver organoids cultured by the traditional glue drop method; Figure 2d is the area representation of patterned liver organoids cultured to different time points; Figure 2e is the patterned liver organoids and Comparison of coefficient of variation (CV value) of liver organoid area by glue drop method;
由图2e可知,图案化肝脏类器官面积变异系数要明显低于胶滴法肝脏类器官;通过图2a和图2c的明场图比较,也能直观看出图案化肝脏类器官限制了类器官生长的区域,具有一致的形状和大小,而胶滴法培养的类器官在这些方面都是不可控的。It can be seen from Figure 2e that the coefficient of variation of the area of patterned liver organoids is significantly lower than that of the gel drop method; by comparing the bright field images of Figure 2a and Figure 2c, it can also be seen intuitively that the patterned liver organoids limit the size of the organoids. The growing regions have a consistent shape and size, which are not controllable in droplet-grown organoids.
最后,还需要说明的是,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者设备不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者设备所固有的要素。Finally, it should also be noted that the term "comprises", "comprises" or any other variation thereof is intended to cover a non-exclusive inclusion such that a process, method, article or apparatus comprising a set of elements includes not only those elements, but also Other elements not expressly listed, or inherent to the process, method, article, or apparatus are also included.
尽管已描述了本发明的优选实施例,但本领域内的技术人员一旦得知了基本创造性概念,则可对这些实施例作出另外的变更和修改。所以,所附权利要求意欲解释为包括优选实施例以及落入本发明范围的所有变更和修改。While preferred embodiments of the invention have been described, additional changes and modifications to these embodiments can be made by those skilled in the art once the basic inventive concept is appreciated. Therefore, it is intended that the appended claims be construed to cover the preferred embodiment as well as all changes and modifications which fall within the scope of the invention.
显然,本领域的技术人员可以对本发明进行各种改动和变型而不脱离本发明的精神和范围。这样,倘若本发明的这些修改和变型属于本发明权利要求及其等同技术的范围之内,则本发明也意图包含这些改动和变型在内。Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalent technologies, the present invention also intends to include these modifications and variations.

Claims (11)

  1. 一种肝脏类器官的培养芯片的制备方法,其特征在于,所述方法包括:A method for preparing a culture chip of liver organoids, characterized in that the method comprises:
    获得具有多个穿孔的薄膜;obtaining a film with a plurality of perforations;
    将细胞低黏附的材料包被在细胞培养板底部,后将所述薄膜覆盖于所述细胞培养板底部,获得图案化基底;coating the bottom of the cell culture plate with a material with low cell adhesion, and then covering the bottom of the cell culture plate with the film to obtain a patterned substrate;
    向所述图案化基底中加入细胞特异性黏附的材料进行包被,获得肝脏类器官的培养芯片。A cell-specific adhesion material is added to the patterned substrate for coating to obtain a culture chip of liver organoids.
  2. 根据权利要求1所述的一种肝脏类器官的培养芯片的制备方法,其特征在于,每个所述穿孔的孔形状包括圆形、椭圆形、半圆形、扇形、三角形、四边形、五边形、六边形和任意多边形中的一种;每个所述穿孔的外接圆直径为100μm~1000μm,所述薄膜的相邻两个所述穿孔的间距为0.5mm~3mm。The method for preparing a liver organoid culture chip according to claim 1, wherein the shape of each perforated hole includes a circle, an ellipse, a semicircle, a fan, a triangle, a quadrangle, and a pentagon. One of shape, hexagon and arbitrary polygon; the diameter of the circumscribed circle of each perforation is 100 μm-1000 μm, and the distance between two adjacent perforations of the film is 0.5 mm-3 mm.
  3. 根据权利要求1所述的一种肝脏类器官的培养芯片的制备方法,其特征在于,所述薄膜的材料包括聚二甲基硅氧烷;所述细胞低黏附的材料包括聚乙二醇;所述细胞特异性黏附的材料包括Matrigel和Collagen中的至少一种。The method for preparing a liver organoid culture chip according to claim 1, wherein the material of the film comprises polydimethylsiloxane; the material with low cell adhesion comprises polyethylene glycol; The material for cell-specific adhesion includes at least one of Matrigel and Collagen.
  4. 根据权利要求1所述的一种肝脏类器官的培养芯片的制备方法,其特征在于,所述获得具有多个穿孔的薄膜,包括:The method for preparing a culture chip of a liver organoid according to claim 1, wherein said obtaining a film with multiple perforations comprises:
    获得具有多个微柱阵列的阳模;obtaining a male mold with a plurality of micropillar arrays;
    将PDMS倒入所述阳模上,真空干燥并抽真空,并在所述PDMS上覆盖一层PMMA,后用两个玻璃片夹紧固定,烘干;Pour the PDMS onto the positive mold, vacuum dry and evacuate, and cover a layer of PMMA on the PDMS, then clamp and fix it with two glass sheets, and dry;
    将凝固的PDMS层取出,并裁剪成适配于细胞培养板形状的PDMS膜,获得具有多个穿孔的薄膜。The solidified PDMS layer was taken out and cut into a PDMS membrane adapted to the shape of the cell culture plate to obtain a thin film with multiple perforations.
  5. 根据权利要求4所述的一种肝脏类器官的培养芯片的制备方法,其特征在于,所述阳膜的所述微柱阵列高度为30μm~100μm。The method for preparing a liver organoid culture chip according to claim 4, characterized in that the height of the microcolumn array of the positive membrane is 30 μm˜100 μm.
  6. 一种采用权利要求1-5任一项所述的方法制备得到的肝脏类器官的培养芯片。A culture chip of liver organoids prepared by the method according to any one of claims 1-5.
  7. 一种肝脏类器官模型的制备方法,其特征在于,所述方法包括:A method for preparing a liver organoid model, characterized in that the method comprises:
    于权利要求6所述的肝脏类器官的培养芯片内接种前肠胚细胞,待细胞贴壁后,将所述具有多个穿孔的薄膜移走,吸除所述的肝脏类器官的培养芯片内的培养基,洗涤后加入第一培养基维持培养3~5天;Inoculate the foregut embryonic cells in the culture chip of the liver organoid according to claim 6, and after the cells adhere to the wall, remove the film with multiple perforations, and suck out the inside of the culture chip of the liver organoid. After washing, add the first medium to maintain the culture for 3 to 5 days;
    后依次采用第二培养基维持培养3~5天和第三培养基维持培养≥10天,获得肝脏类器官模型。Afterwards, the second culture medium was used to maintain culture for 3 to 5 days and the third culture medium for ≥10 days to obtain a liver organoid model.
  8. 根据权利要求7所述的一种肝脏类器官模型的制备方法,其特征在于,所述前肠胚 细胞的接种密度为1×10 5~9×10 5(个/cm 2)。 The preparation method of a liver organoid model according to claim 7, characterized in that the inoculation density of the foregut germ cells is 1×10 5 -9×10 5 (cells/cm 2 ).
  9. 一种利用权利要求1~8任意一项所述的方法获得的肝脏类器官模型。A liver organoid model obtained by the method according to any one of claims 1-8.
  10. 一种权利要求9所述的肝脏类器官模型在药理学、药效学、毒理学分析中的应用。An application of the liver organoid model according to claim 9 in pharmacology, pharmacodynamics and toxicology analysis.
  11. 根据权利要求4所述的一种肝脏类器官的培养芯片的制备方法,其特征在于,所述穿孔的薄膜包括模型成型的多孔PDMS/有机硅薄膜或打孔器穿孔的多孔PDMS/有机硅薄膜。The method for preparing a culture chip of a liver organoid according to claim 4, wherein the perforated film comprises a molded porous PDMS/organic silicon film or a porous PDMS/organic silicon film perforated by a puncher .
PCT/CN2022/140800 2021-12-24 2022-12-21 Liver organoid culture chip, liver organoid model, preparation methods therefor, and application WO2023116788A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202111594737.7A CN114276903A (en) 2021-12-24 2021-12-24 Liver organoid culture chip, liver organoid model, and preparation method and application thereof
CN202111594737.7 2021-12-24

Publications (1)

Publication Number Publication Date
WO2023116788A1 true WO2023116788A1 (en) 2023-06-29

Family

ID=80875491

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/140800 WO2023116788A1 (en) 2021-12-24 2022-12-21 Liver organoid culture chip, liver organoid model, preparation methods therefor, and application

Country Status (2)

Country Link
CN (1) CN114276903A (en)
WO (1) WO2023116788A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114276903A (en) * 2021-12-24 2022-04-05 武汉大学 Liver organoid culture chip, liver organoid model, and preparation method and application thereof
CN116731859B (en) * 2023-05-12 2024-04-30 武汉大学 Annular brain organoid model and construction method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105176816A (en) * 2015-10-30 2015-12-23 东南大学 Micro-vessel liver chip based on cell clusters and making method and using method thereof
CN108277198A (en) * 2018-01-09 2018-07-13 大连理工大学 A kind of liver micro-fluidic chip and its application for realizing that two dimension, three dimensional intersection co-culture
CN112680348A (en) * 2020-12-31 2021-04-20 北京大橡科技有限公司 Organ model construction method based on organ chip and organ model
CN113667603A (en) * 2021-08-13 2021-11-19 武汉大学 Liver organoid culture chip and preparation method and application thereof
CN114276903A (en) * 2021-12-24 2022-04-05 武汉大学 Liver organoid culture chip, liver organoid model, and preparation method and application thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105176816A (en) * 2015-10-30 2015-12-23 东南大学 Micro-vessel liver chip based on cell clusters and making method and using method thereof
CN108277198A (en) * 2018-01-09 2018-07-13 大连理工大学 A kind of liver micro-fluidic chip and its application for realizing that two dimension, three dimensional intersection co-culture
CN112680348A (en) * 2020-12-31 2021-04-20 北京大橡科技有限公司 Organ model construction method based on organ chip and organ model
CN113667603A (en) * 2021-08-13 2021-11-19 武汉大学 Liver organoid culture chip and preparation method and application thereof
CN114276903A (en) * 2021-12-24 2022-04-05 武汉大学 Liver organoid culture chip, liver organoid model, and preparation method and application thereof

Also Published As

Publication number Publication date
CN114276903A (en) 2022-04-05

Similar Documents

Publication Publication Date Title
WO2023116788A1 (en) Liver organoid culture chip, liver organoid model, preparation methods therefor, and application
Wang et al. Engineering stem cell-derived 3D brain organoids in a perfusable organ-on-a-chip system
Zhu et al. In situ generation of human brain organoids on a micropillar array
JP4567936B2 (en) Support material for cell culture, cell co-culture method and co-culture cell sheet obtained therefrom
Sodunke et al. Micropatterns of Matrigel for three-dimensional epithelial cultures
EP2551341B1 (en) Culture method for causing differentiation of pluripotent mammalian cells
Cho et al. Layered patterning of hepatocytes in co-culture systems using microfabricated stencils
US20140295553A1 (en) In-vitro cell colony culture device and use thereof
US9828576B2 (en) Cell culture
KR20140072883A (en) Engineered tissues for in vitro research uses, arrays thereof, and methods of making the same
WO2014085933A1 (en) Cardiac tissue constructs and methods of fabrication thereof
EP2195413A1 (en) Compliant surface multi-well culture plate
Versaevel et al. Micropatterning hydroxy-PAAm hydrogels and Sylgard 184 silicone elastomers with tunable elastic moduli
JPWO2010047132A1 (en) Cell culture kit, screening method, and method for producing cell culture kit
Frum et al. hPSC-derived organoids: models of human development and disease
WO2023160688A1 (en) Brain organoid model, method for preparing same and use thereof
TW201014914A (en) Materials and methods for cell growth
Sozzi et al. Silk scaffolding drives self-assembly of functional and mature human brain organoids
JP5940758B2 (en) Cell culture method
Giacomini et al. Microfluidically aligned collagen to maintain the phenotype of tenocytes in vitro
Yoshimoto et al. Recapitulation of human embryonic heartbeat to promote differentiation of hepatic endoderm to hepatoblasts
US20200332252A1 (en) Hollow microcarrier for shear-free culture of adherent cells in bioreactors
Javaherian et al. Micropatterning cells on permeable membrane filters
Patel Engineering 2D and 3D Human Skeletal Muscle Models
Bosch-Fortea et al. Methods to Generate Tube Micropatterns for Epithelial Morphogenetic Analyses and Tissue Engineering

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22910100

Country of ref document: EP

Kind code of ref document: A1